Nilay Thakar is a Principal at ARCH Venture Partners, joining as an Analyst in 2017 and later as an Associate in 2018. He co-founded Skylark Bio and supported investments in Ally Therapeutics and One BioMed.
At firms with a similar stage, sector and check size.
One email when Nilay's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckNilay Thakar is a Principal at ARCH Venture Partners, joining as an Analyst in 2017 and later as an Associate in 2018. He co-founded Skylark Bio and supported investments in Ally Therapeutics and One BioMed.
Nilay Thakar invests through Arch Venture Partners, which writes checks of $25K to $30M+ at pre-seed, seed, series a, series b.
A warm intro from a founder Arch Venture Partners backed works best.
Last updated 2026-10-15. Is this you? Ask for a correction.